Market revenue in 2023 | USD 1,460.2 million |
Market revenue in 2030 | USD 2,234.4 million |
Growth rate | 6.3% (CAGR from 2023 to 2030) |
Largest segment | Product registration & clinical trial applications |
Fastest growing segment | Legal representation |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Regulatory consulting, Legal representation, Regulatory writing & publishing, Product registration & clinical trial applications, Regulatory Submissions, Regulatory Operations, Other services |
Key market players worldwide | Genpact Ltd, Criterium Inc., Promedica International, Wuxi AppTec Co Ltd, Medpace Holdings Inc, Charles River Laboratories International Inc, Icon PLC, Labcorp Drug Development, FREYR Battery Inc, Cencora Inc, Pharmexon, QVigilance, BlueReg Group, ZEINCRO Group |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to regulatory affairs outsourcing market will help companies and investors design strategic landscapes.
Product registration & clinical trial applications was the largest segment with a revenue share of 25.96% in 2023. Horizon Databook has segmented the Europe regulatory affairs outsourcing market based on regulatory consulting, legal representation, regulatory writing & publishing, product registration & clinical trial applications, regulatory submissions, regulatory operations, other services covering the revenue growth of each sub-segment from 2018 to 2030.
Europe is a decentralized pharmaceutical market. Entry in the European market requires players to possess extensive knowledge about different regulatory procedures in various member states of the European Union.
Small- and mid-size biopharmaceutical companies that do not have a regulatory affairs department usually hire a regulatory consultant or a legal representative to assist them through various stages of regulatory approval processes required for commercializing their product in Europe.
The European Medicine Agency (EMA), Europe’s regulatory agency covers 25.0% market of worldwide pharmaceutical sales and this is one of the leading drivers for outsourcing trend related to regulatory affairs in the life sciences sector as higher number of drugs for regulatory approval would mean greater demand for regulatory services by life sciences companies in the region.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe regulatory affairs outsourcing market , including forecasts for subscribers. This continent databook contains high-level insights into Europe regulatory affairs outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account